Cargando…
First Therapeutic Approval for Eosinophilic Esophagitis
Eosinophilic esophagitis (EE) is a chronic, immune-mediated or antigen-mediated esophageal disease. Treatment for patients with EE can be challenging with no previously approved medications. Current management strategies follow the four D’s paradigm of drugs, dietary elimination, dilation, and disea...
Autores principales: | Al-Horani, Rami A., Chiles, Raquel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9364827/ https://www.ncbi.nlm.nih.gov/pubmed/35967984 http://dx.doi.org/10.3390/gastroent13030024 |
Ejemplares similares
-
Vericiguat: A New Hope for Heart Failure Patients
por: Chiles, Raquel, et al.
Publicado: (2022) -
Eosinophilic esophagitis: Immune mechanisms and therapeutic targets
por: Khokhar, Dilawar, et al.
Publicado: (2022) -
Potential Therapeutic Roles for Direct Factor Xa Inhibitors in Coronavirus Infections
por: Al-Horani, Rami A.
Publicado: (2020) -
Esophageal Trachealization: A Feature of Eosinophilic Esophagitis
por: Al-Hussaini, Abdulrahman A., et al.
Publicado: (2009) -
Esophageal Microbiome in Eosinophilic Esophagitis
por: Harris, J. Kirk, et al.
Publicado: (2015)